Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Pharm Res. 2013 Dec 3;31(4):1046–1058. doi: 10.1007/s11095-013-1226-x

Fig. 4.

Fig. 4

Representative ocular fluorescence images of the eye after subconjunctival injection of pRNA-X in whole-body imaging. (a) 2 h time point; (b) 4 h time point after the injection. The white color represents high fluorescence intensity beyond the scale.